by Aspirion | Apr 3, 2025 | No Surprises Act, Revenue Cycle Management
Recent data from the U.S. Department of Health and Human Services reveals a striking fact: healthcare providers won 77% of nearly 84,000 Independent Dispute Resolution (IDR) decisions in the first half of 2023. Yet many hospitals and healthcare systems aren’t...
by Aspirion | Apr 1, 2025 | News
COLUMBUS, Ga., April 1 /PRNewswire/ — Aspirion, the healthcare technology revenue cycle management (“RCM”) leader for denials, payment variance, and complex claims, today announced the appointment of Scott Doolittle as its Chief Financial Officer (“CFO”) effective...
by Aspirion | Mar 27, 2025 | Denials Management
CASE STUDY Denials Management Over $53 Million Recovered in Overturned Clinical Denials Download Case Study At a Glance Challenges Complex clinical denials for new medical technology labeled as “experimental” Multiple appeal levels required, including...
by Aspirion | Mar 25, 2025 | Denials Management, Payment Variance Recovery, Revenue Cycle Management
Hospitals and healthcare systems nationwide are experiencing an alarming increase in diagnosis-related group (DRG) downgrades. This emerging trend poses significant financial and operational challenges for providers already navigating razor-thin operating margins. But...
by Aspirion | Mar 20, 2025 | Payment Variance Recovery, Revenue Cycle Management, Zero Balance Review
Zero-balance reviews (ZBRs) have emerged as a powerful tool for recovering missed revenue opportunities. As ZBR experts who partner with healthcare providers nationwide, we’ve witnessed the growing need for this strategic approach. While the financial benefits...
by Aspirion | Mar 18, 2025 | No Surprises Act, Revenue Cycle Management
Since the No Surprises Act (NSA) took effect on January 1, 2022, healthcare providers have faced significant revenue cycle challenges while adapting to this complex legislation. While the NSA protects patients from unexpected medical bills, it has created substantial...
by Aspirion | Mar 13, 2025 | No Surprises Act, Revenue Cycle Management
While the No Surprises Act (NSA) aims to protect patients from unexpected medical bills, it has created substantial financial and administrative challenges for hospitals and healthcare systems nationwide. Since its implementation on January 1, 2022, healthcare...
by Aspirion | Mar 10, 2025 | Motor Vehicle Accident, Patient Advocacy & Patient Experience, Revenue Cycle Management
Patient advocacy has emerged as an important component that serves both patients and healthcare providers alike. Beyond improving the patient experience for motor vehicle accident (MVA) and third-party liability (TPL) patients, a well-structured advocacy program...
by Aspirion | Mar 4, 2025 | Motor Vehicle Accident, Patient Advocacy & Patient Experience, Revenue Cycle Management
Hospital patients often find themselves navigating a labyrinth of insurance policies, billing procedures, and coverage options—all while dealing with the physical and emotional stress of injury or illness. This challenge becomes particularly acute for patients...
by Aspirion | Feb 27, 2025 | Artificial Intelligence (AI), Denials Management, Revenue Cycle Management
In a recent HFMA Region 8 webinar, “AI in Denials Management: From Concept to Reality,” Aspirion’s Jim Bohnsack, Chief Strategy & Client Officer, and Spencer Allee, Chief AI Officer, provided an insightful look into how artificial intelligence (AI) is...
